Clinical Trials in Baltimore

Showing 3401-3420 of 11,213 trials

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

NCT04626583

This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of locally delivered allogeneic mesenchymal stromal cells (MSC) for promoting corneal repair. The study will be conducted at Illinois Eye and Ear Infirmary located at University of Illinois at Chicago. The study will use digital conjunctival and corneal photography and corneal Scheimpflug Imaging, densitometry, and pachymetry for assessment of safety and corneal wound healing.

Mesenchymal Stromal CellsCorneaSafety+1 more

University of Illinois at Chicago8 participantsStarted Mar 2021

Chicago, Illinois, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Study of ATH434 in Participants with Multiple System Atrophy

NCT05109091

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Multiple System Atrophy

Alterity Therapeutics77 participantsStarted Jul 2022

La Jolla, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +20 more locations

Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Study of ATH434 in Participants with Multiple System Atrophy

Find Trials by Condition in Baltimore

Preventing Postpartum Depression in Immigrant Latinas

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Skin Immunity Sample Collection Involving Blisters and Biopsies

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

A Drug-drug Interaction Study of Avapritinib and Midazolam

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

AAV Gene Therapy Study for Subjects with PKU

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Nitrous Oxide for the Treatment of Major Depressive Disorder